OR
OR Royalties Inc.
$34.55
-0.23
(-0.66%)
Mkt Cap
6.57B
Volume
331,708
52W Range
27.54-48.06
Sector
Basic Materials
Beta
1.32
EPS (TTM)
1.51 USD
P/E Ratio
23.19
Revenue (TTM)
362.63M USD
Rev Growth (5Y)
+5.7%
EPS Growth (5Y)
+62.1%
AlphaVal · Fair Value
What we estimate one share is worth
$5.83
Overvalued
strong signal
500.9% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Other Commodity Producers
64.8 / 100 composite
A commodity producer — graded A–F vs. similar companies.
Company Description
OR Royalties Inc. specializes in acquiring, developing, and exploring for valuable metals, along with securing various royalty and streaming arrangements. A significant holding for the company is its ownership interest in the Canadian Malartic mine. This firm was established on April 29, 2014, and its primary corporate office is located in Montreal, Canada.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 282.00M | 191.16M | 183.23M | 160.48M | 176.37M | 213.63M | 392.60M | 490.47M | 213.22M | 62.68M | 45.41M | 17.18M |
| Net Income | 209.52M | 16.27M | (37.43M) | (87.50M) | (18.47M) | 16.88M | (234.19M) | (105.59M) | (42.50M) | 42.11M | 28.75M | 1.67B |
| EPS | 1.12 | 0.09 | -0.20 | -0.49 | -0.11 | 0.10 | -1.55 | -0.67 | -0.33 | 0.40 | 0.33 | 36.40 |
| Free Cash Flow | 212.20M | 60.09M | (78.53M) | (14.26M) | 11.85M | (29.91M) | 7.46M | (59.05M) | (31.54M) | (1.91M) | 28.84M | 123.00M |
| FCF / Share | 1.13 | 0.32 | -0.42 | -0.08 | 0.07 | -0.18 | 0.05 | -0.38 | -0.25 | -0.02 | 0.33 | 2.68 |
| Operating CF | 249.69M | 111.13M | 141.11M | 109.95M | 83.21M | 107.98M | 91.60M | 82.16M | 48.72M | 53.44M | 29.14M | 124.09M |
| Total Assets | 1.57B | 957.32M | 1.49B | 2.00B | 2.37B | 2.40B | 1.53B | 2.23B | 2.52B | 1.42B | 1.08B | 269.96M |
| Total Debt | 8.77M | 68.57M | 151.13M | 155.57M | 410.44M | 411.80M | 276.98M | 352.77M | 464.31M | 45.78M | 0 | 0 |
| Cash & Equiv | 141.76M | 41.07M | 51.20M | 90.55M | 115.70M | 302.52M | 83.46M | 174.26M | 333.70M | 499.25M | 258.51M | 175.17M |
| Book Value | 1.43B | 826.20M | 1.25B | 1.74B | 1.63B | 1.73B | 1.15B | 1.77B | 1.89B | 1.21B | 935.84M | 263.23M |
| Return on Equity | 0.15 | 0.02 | -0.03 | -0.05 | -0.01 | 0.01 | -0.20 | -0.06 | -0.02 | 0.03 | 0.03 | 6.36 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 97.82M | 101.41M | 91.78M | 71.62M | 44.31M | 38.56M | 55.82M | 56.77M | 47.39M | 45.05M | 52.42M | 62.07M |
| Net Income | 61.39M | 72.56M | 66.19M | 82.84M | 23.75M | 18.00M | 7.20M | 18.13M | (15.42M) | 11.17M | (50.28M) | (20.00M) |
| EPS | 0.33 | 0.39 | 0.35 | 0.44 | 0.12 | 0.10 | 0.04 | 0.10 | -0.11 | 0.08 | -0.37 | -0.11 |
| Free Cash Flow | (199.72M) | (26.31M) | 84.83M | 36.26M | 33.45M | 40.79M | (8.23M) | 24.29M | 38.23M | 37.19M | (646,606) | 16.70M |
| FCF / Share | -1.06 | -0.14 | 0.45 | 0.19 | 0.18 | 0.22 | -0.04 | 0.13 | 0.21 | 0.20 | -0.00 | 0.09 |
| Operating CF | 83.17M | 70.87M | 84.81M | 45.96M | 51.38M | 46.08M | 33.41M | 34.94M | 38.23M | 37.19M | 38.27M | 43.46M |
| Total Assets | 1.86B | 1.61B | 1.57B | 1.51B | 1.44B | 1.39B | 957.32M | 1.38B | 1.38B | 1.96B | 2.01B | 2.18B |
| Total Debt | 219.28M | 4.65M | 8.77M | 5.26M | 41.30M | 80.02M | 68.57M | 65.07M | 85.00M | 159.67M | 199.88M | 323.66M |
| Cash & Equiv | 75.61M | 95.25M | 141.76M | 56.91M | 49.63M | 63.07M | 41.07M | 43.33M | 47.98M | 70.60M | 67.72M | 70.75M |
| Book Value | 1.48B | 1.48B | 1.43B | 1.39B | 1.29B | 1.21B | 826.20M | 1.23B | 1.21B | 1.68B | 1.65B | 1.74B |
| Return on Equity | 0.04 | 0.05 | 0.05 | 0.06 | 0.02 | 0.01 | 0.01 | 0.01 | -0.01 | 0.01 | -0.03 | -0.01 |
OR News
Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases
Osisko Gold: I Tried To Break The Bull Case, And I'm Still Buying
Is OR Royalties (OR) a Solid Growth Stock? 3 Reasons to Think "Yes"
OR Royalties Announces Preliminary Q3 2026 GEO Deliveries
Osisko Gold Intersects 7.28 g/t Au over 16.15 m (105 m Vertical Depth), including 173.66 g/t Au over 0.60 m, and 7.13 g/t Au over 11.60 m (61 m Vertical Depth) in Lowhee Zone Underground Infill Drilling at Cariboo Gold Project
Head-To-Head Contrast: USA Rare Earth (NASDAQ:USAR) and OR Royalties (NYSE:OR)
Osisko Gold Announces Management Update
Osisko Gold Completes US$600 Million Aggregate Principal Amount of 9.250% Senior Secured Notes Offering
OR Royalties Inc (OR) Stock Down 4.2% -- Now Undervalued? GF Score: 91/100
Osisko Gold Royalties (TSE:OR) Share Price Breaks Above 50-Day Moving Average – Should You Sell?